Navigation Links
Breast tumors in mice eradicated using cancer vaccine

Findings could lead to new immune therapy for breast cancer

A team from the University of Pennsylvania School of Medicine has shown that by using a cancer vaccine based on the bacterium Listeria monocytogenes, they can cure mice with established breast tumors. Cancer vaccines, which are more properly described as immunotherapy, work by boosting an immune response against tumor-associated antigens.

Using Listeria, the researchers, led by Yvonne Paterson, PhD, Professor of Microbiology, delivered the tumor-associated antigen HER-2/Neu to immune cells. HER-2/Neu is overexpressed in 20 to 40 percent of all breast cancers and also present in many cancers of the ovaries, lung, pancreas, and gastrointestinal tract. These cells eventually enlist killer T cells to seek out and destroy the tumor cells that display the HER-2/Neu molecule.

"We found that we can stop the tumor from growing out to 100 days, at which time we stopped measuring since this is a long time for experiments of this type," says Paterson. "The tumors stopped growing or went completely away." The researchers published their findings in the September 15 issue of the Journal of Immunology.

"The problem that we encounter is that often by the time a patient presents with cancer, they've developed immune tolerance to the tumor antigen, particularly when the antigen is expressed at low levels on normal tissue as with Her2/Neu," explains Paterson. "So how is the body to mount a strong enough immune reaction?"

In general, bacteria are good at inducing both innate and adaptive immune responses, activating such immune cells as macrophages, dendritic cells, and T cells. This helps jump-start the immune response to break tolerance.

But, why Listeria over other bacteria as a vehicle to deliver a tumor-associated antigen? Because of Listeria's unusual life style. Normally, when bacteria get taken up into an antigen-presenting cell, they are engulfed by a phagocytic vacuol
'"/>

Source:University of Pennsylvania School of Medicine


Page: 1 2 3

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Deficient DNA Repair Capacity Associated With Increased Risk Of Breast Cancer
3. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
4. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
5. New Breast Cancer Test Could Save Lives
6. Breast Cancer May Be Uniquely Sensitive To Inhibitors Of PI3K Pathway
7. Breast-Cancer Risk Linked to Exposure to Traffic Emissions at Menarche, First Birth
8. Nanoparticle Breast Cancer Drug Approved by FDA
9. Genpathway and Baylor College of Medicine Identify New Genes in Breast Cancer
10. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
11. Affymetrix and bioMerieux Extend Their Agreement on GeneChip(R) Technology to Breast Cancer Diagnostics

Post Your Comments:
(Date:11/23/2009)...ence that the "synergistic" effect of early-life e...and indoor endotoxin causes more harm to developin... Environmental health scientists at the Universit...n that children exposed to both high levels of tra... early life are six times more likely to experienc...
(Date:11/23/2009)...day matters to forest trees dealing with drought, ...am led by Professor Malcolm Campbell, University o...h and colleagues in the department of cell and sys...alizing on their previous work to decode the genom...ow poplar trees use their 45,000 genes to respond ...
(Date:11/23/2009)...hat a common oral bacterium may exacerbate autoimm... "Unique Lipids from a Common Human Bacterium Repr...cing Autoimmunity," appears in the December 2009 i...ultiple sclerosis (MS), a disease where the immune... nearly 1 in 700 people in the United States. Pat...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2Nephrologists Indicate High Interest in AMAG Pharmaceuticals Newly Approved Feraheme According to Latest BioTrends Report 53682 1Nephrologists Indicate High Interest in AMAG Pharmaceuticals Newly Approved Feraheme According to Latest BioTrends Report 53682 2Nephrologists Indicate High Interest in AMAG Pharmaceuticals Newly Approved Feraheme According to Latest BioTrends Report 53682 3100+ Nurses to Rally in SF Wed to Demand Stronger Swine Flu Safety Protections 3A California Hospitals Remain Unprepared Despite First Nurse Death 53680 1100+ Nurses to Rally in SF Wed to Demand Stronger Swine Flu Safety Protections 3A California Hospitals Remain Unprepared Despite First Nurse Death 53680 2100+ Nurses to Rally in SF Wed to Demand Stronger Swine Flu Safety Protections 3A California Hospitals Remain Unprepared Despite First Nurse Death 53680 3Abnormal Brain Circuits May Prevent Movement Disorder 53678 1Abnormal Brain Circuits May Prevent Movement Disorder 53678 2Abnormal Brain Circuits May Prevent Movement Disorder 53678 3Abnormal Brain Circuits May Prevent Movement Disorder 53678 4
...05 flu season was at least as severe as the 2003-2...m Solucient, a leading provider of healthcare info...st recent flu season from being even worse. , A fl...sions for community-acquired pneumonia (CAP), one ...ient analyzed CAP discharge data from October 2002...
...to a new treatment for nerve damage caused by diab...tients, say experts. , The treatment might also r...f early effects on nerve protection and regenerati...tes is the major cause of non-traumatic lower limb...ists at The University of Manchester, working with...
...ng with Arabidopsis, a fast-growing cousin of the ... of North Carolina at Chapel Hill got a big surpri...ks from disease organisms such as bacteria and vir...r experiments showed that at least three different...of war or teeter totter-fashion to keep plant defe...
Other Biology News:Diabetic nerve therapy shows 'striking' results 2FDA approves more generic AIDS drugs 2FDA approves more generic AIDS drugs 3
(Date:11/24/2009)...KJAVIK,Iceland,November24/PRNewswire-FirstCall/--d...atithasreceivednoticefrom,theNasdaqStockMarketthat...ofNovember30,2009andaForm25-NSEwillbefiledwiththe,...ODE,scommonstock,fromlistingonNasdaq,unlessthecomp...anel.Thecompanyhasfiledsuchanappeal,which,willstay...
(Date:11/24/2009)... Health care employment grew by 29...ly one to show consistent growth during the U.S. r... remain in trouble, and health systems are coming ..., instead of just administrators. , ...e employment continued growing in October despite ...
(Date:11/24/2009)...NGHAI,Nov.24/PRNewswire-Asia/--NODPharmaceuticalsI...asallowedthepatentapplicationfor,itsnano-particleo...ahighlyefficientapproachtoincorporatepeptidesor,pr...liveryofdrugs,otherwiseadministeredasinjections.NO...omanymacromoleculardrugssuchasinsulin,interferon,...
(Date:11/24/2009)...NGHAI,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxyanno...FDA)hasapprovedthe,investigationalnewdrugapplicati...iveinsulinformulationtotreatdiabetes.ThisIND,appro...udy. , Diabetesisadisordercharacteristicofhig...diabetesoftenresultinseveremicro-and,macro-vascula...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2
...ds, March 10 Two clinical,psychologists associate...lland, Jaap Hollander and Jeffrey Wijnberg, have d...Mentor." MindMentor is an online computer,program .... It has the,unique quality, as compared with othe...no live human intervention and being completely au...
...ams Up with YWCA & Roche to Educate Patients on, ...Cancer and a Career -, NEW YORK, March 10 In rec...cer and Careers, a non-profit program,founded by C...launching a,seminar which offers guidance for the ... on how to return to work after a cancer diagnosis...
...nd, Jr., J.D., joins BrainCells, Board of ... 10 BrainCells Inc. (BCI), a,biopharmaceutical co...y and,develop compounds that promote the growth of...system (CNS) diseases, announced today that it has...ries B financing. New,investor MedImmune Ventures ...
Other Biology Technology:Robot Psychologist: A New Era in Mental Health Services With MindMentor 2First-Ever 'Cancer and Careers' Seminar Debuts in Orange County 2First-Ever 'Cancer and Careers' Seminar Debuts in Orange County 3BrainCells Inc. Completes $30 Million Initial Closing of Series B Financing 2
Canine IFN-gamma ELISA Kit from R&D Systems
Non-Protein Peroxidase Stabilizer from BioFX Laboratories, Inc.
... Lysate contains the cellular components necessary...ds, initiation, elongation and termination factors...se. Untreated Lysate is used primarily for the iso...ce of endogenous globin mRNA. Untreated Lysate is ...
MagCellect Magnet from R&D Systems
Biology Products: